1. Multiple sclerosis: epidemiological and HLA associations;McDonald, W.I.,1984
2. Histocompatibility determinants in multiple sclerosis with special reference to clinical course;Jersild, C.; Fog, T.; Hansen, G.S.; Thomsen, M.; Svejgaard, A.; Dupont, B.;Lancet,1973
3. Genetic basis of multiple sclerosis: HLA antigens, disease progression and oligoclonal IgG in CSF;Stendahl-Brodin, L.; Link, H.; Moller, E.; Norrby, E.;Acta Neurol Scand,1979
4. Correlation of the course of MS and histocompatibility antigens;Raun, N.E.; Fog, T.; Heltberg, A.; Platz, P.,1980
5. Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis. Final report;Mertin, J.; Rudge, P.; Kremer, M.;Lancet,1982